[Ip-health] Financial Times: Japan's Daiichi pays $4.6 billion for Ranbaxy

[Miles Teg]

Be interesting to know how much of Indian generic producer production is
targeted at the developed world especially since Monopolist BigPharma
states that it will increase outsourcing of production... cos it is not
just ownership that matters - your customers also matter... any research
or numbers on this?


Thiru Balasubramaniam wrote:
> http://www.ft.com/cms/s/0/25a46440-3780-11dd-aabb-0000779fd2ac.html
>
> Japan=92s Daiichi pays $4.6bn for Ranbaxy
>
> By Joe Leahy in Mumbai
>
> Published: June 11 2008 07:33 | Last updated: June 11 2008 09:05
>
> Japan=92s Daiichi Sankyo is to buy Ranbaxy Laboratories, India=92s bigges=
t
> generic drugs maker, in a deal worth up to $4.6bn.
>
>